Mueller BU - Search Results

1

Heterozygous PU.1 mutations are associated with acute myeloid leukemia.

Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD, Behre G, Hiddemann W, Ito Y, Tenen DG. Mueller BU, et al. Blood. 2002 Aug 1;100(3):998-1007. doi: 10.1182/blood.v100.3.998. Blood. 2002. PMID: 12130514 Free article.

2

Heterozygous PU.1 mutations are associated with acute myeloid leukemia.

Mueller BU, Pabst T, Osato M, Asou N, Johansen LM, Minden MD, Behre G, Hiddemann W, Ito Y, Tenen DG. Mueller BU, et al. Blood. 2003 Mar 1;101(5):2074. doi: 10.1182/blood-2002-12-3903. Blood. 2003. PMID: 12584148 Free article. No abstract available.

3

ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.

Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG. Mueller BU, et al. Blood. 2006 Apr 15;107(8):3330-8. doi: 10.1182/blood-2005-07-3068. Epub 2005 Dec 13. Blood. 2006. PMID: 16352814 Free PMC article.

4

Heterozygous deletion of the PU.1 locus in human AML.

Bonadies N, Pabst T, Mueller BU. Bonadies N, et al. Among authors: mueller bu. Blood. 2010 Jan 14;115(2):331-4. doi: 10.1182/blood-2009-03-212225. Epub 2009 Nov 4. Blood. 2010. PMID: 19890096 Free article.

5

PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding.

Zhang P, Zhang X, Iwama A, Yu C, Smith KA, Mueller BU, Narravula S, Torbett BE, Orkin SH, Tenen DG. Zhang P, et al. Among authors: mueller bu. Blood. 2000 Oct 15;96(8):2641-8. Blood. 2000. PMID: 11023493 Free article.

6

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.

Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG. Pabst T, et al. Among authors: mueller bu. Nat Genet. 2001 Mar;27(3):263-70. doi: 10.1038/85820. Nat Genet. 2001. PMID: 11242107

7

AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G, Hiddemann W, Zhang DE, Tenen DG. Pabst T, et al. Among authors: mueller bu. Nat Med. 2001 Apr;7(4):444-51. doi: 10.1038/86515. Nat Med. 2001. PMID: 11283671

8

C/EBPalpha and the pathophysiology of acute myeloid leukemia.

Mueller BU, Pabst T. Mueller BU, et al. Curr Opin Hematol. 2006 Jan;13(1):7-14. doi: 10.1097/01.moh.0000190110.08156.96. Curr Opin Hematol. 2006. PMID: 16319681 Review.

9

Complexity of CEBPA dysregulation in human acute myeloid leukemia.

Pabst T, Mueller BU. Pabst T, et al. Among authors: mueller bu. Clin Cancer Res. 2009 Sep 1;15(17):5303-7. doi: 10.1158/1078-0432.CCR-08-2941. Epub 2009 Aug 25. Clin Cancer Res. 2009. PMID: 19706798 Review.

10

Deficient CEBPA DNA binding function in normal karyotype AML patients is associated with favorable prognosis.

Fos J, Pabst T, Petkovic V, Ratschiller D, Mueller BU. Fos J, et al. Among authors: mueller bu. Blood. 2011 May 5;117(18):4881-4. doi: 10.1182/blood-2010-11-320747. Epub 2011 Mar 9. Blood. 2011. PMID: 21389317 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters